Citadel Advisors
NKTX icon

Citadel Advisors’s Nkarta NKTX Stock Holding History

Citadel Advisors’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,700
Closed -$25.2K – 14211
2025
Q1 		$25.2K Sell
13,700
-3,900
-22% -$8K ﹤0.01% 12965
2024
Q4 		$43.8K Sell
17,600
-35,900
-67% -$111K ﹤0.01% 12534
2024
Q3 		$242K Buy
53,500
+10,500
+24% +$59.7K ﹤0.01% 9753
2024
Q2 		$254K Sell
43,000
-3,900
-8% -$27.6K ﹤0.01% 9459
2024
Q1 		$507K Buy
46,900
+23,900
+104% +$249K ﹤0.01% 8371
2023
Q4 		$152K Buy
23,000
+18,500
+411% +$47.9K ﹤0.01% 10360
2023
Q3 		$6.25K Buy
4,500
+800
+22% +$1.52K ﹤0.01% 13330
2023
Q2 		$8.1K Sell
3,700
-6,200
-63% -$27.3K ﹤0.01% 13339
2023
Q1 		$35.1K Sell
9,900
-500
-5% -$2.37K ﹤0.01% 12581
2022
Q4 		$62.3K Sell
10,400
-180,600
-95% -$1.82M ﹤0.01% 11868
2022
Q3 		$2.51M Sell
191,000
-48,600
-20% -$695K ﹤0.01% 5153
2022
Q2 		$2.95M Buy
239,600
+120,900
+102% +$1.59M ﹤0.01% 4784
2022
Q1 		$1.35M Buy
118,700
+93,400
+369% +$999K ﹤0.01% 6985
2021
Q4 		$388K Buy
+25,300
New +$434K ﹤0.01% 10294

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
GP
GSK plc London $599M AUM
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors's NKTX Position: Q1 2026 in Review

Citadel Advisors increased its Nkarta (NKTX) stake by 33% in Q1 2026, buying an estimated $981K and bringing the position to 1,783,994 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #4829.

Citadel Advisors first reported a position in NKTX in Q2 2021 and has held it in 18 quarters since. The position peaked at $18.5M in Q2 2024. 126 funds tracked by Wall St. Rank hold NKTX as of Q1 2026.

  • Citadel Advisors held 1,783,994 shares of Nkarta worth $3.76M as of Q1 2026.
  • Citadel Advisors bought 438,761 Nkarta shares in Q1 2026, an estimated $981K.
  • Nkarta made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4829 holding.
  • Citadel Advisors first reported a position in Nkarta in Q2 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Nkarta position peaked at $18.5M in Q2 2024.
  • 126 funds tracked by Wall St. Rank held Nkarta as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.